COVID19 Update: For your safety, you will be asked to use a mask, if you do not have one, a mask will be provided. If a person presents with a temperature, you will be asked to return home and further instructions will be given by your health care team. For our patients protection, no visitors under 18 will be allowed in the offices, there is a limit one (1) visitor per patient if necessary. No visitors are allowed in the chemo infusion room. Telemedicine are available for routine office visits. More Information-PLEASE CLICK HERE

ASCO Approves the First Joint MSTS/ASTRO/ASCO Guideline on the Treatment of Metastatic Carcinoma and Myeloma of the Femur - Felasfa M. Wodajo, MD

Virginia Cancer Specialists Practice Blog

February 26, 2021
Virginia Cancer Specialists » VCS Practice News » Physicians » VCS Practice News » Felasfa M. Wodajo MD » ASCO Approves the First Joint MSTS/ASTRO/ASCO Guideline on the Treatment of Metastatic Carcinoma and Myeloma of the Femur – Felasfa M. Wodajo, MD

Felasfa M. Wodajo, MD – On June 20, 2020, ASCO approved the first joint Musculoskeletal Tumor Society (MSTS)/American Society of Radiation Oncologists (ASTRO)/ASCO guideline on the care of patients with metastatic carcinoma and myeloma of the femur. Guideline recommendations were based on a systematic review of clinical trials and observational studies published between January 1946 and July 2019, and clinical experience. Studies conducted on at least 10 patients were included in the review. See Guideline Here